NCT04745910
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Tumor Lysis Syndrome
Explore clinical trials studying Tumor Lysis Syndrome. Study availability and eligibility vary by location and protocol.
8 public trials
0 recruiting studies
Tumor Lysis Syndrome trial results
NCT00186940
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hyperuricemia, +11 more
- Locations
-
- Stanford University Palo Alto, California, United States
- Rady Children's Hospital San Diego, California, United States
- Peyton Manning Children's Hospital at St. Vincent Indianapolis, Indiana, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT01724528
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
Not specified
NCT00628628
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +19 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00360438
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
Completed
Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome
NCT00230178
- Conditions
- Bone Marrow Diseases, Cancer, Hematologic Diseases, +14 more
- Locations
-
- Alta Bates Comprehensive Cancer Center Berkeley, California, United States
- UCLA Medical Center Los Angeles, California, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
- University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States
NCT00230217
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Alta Bates Comprehensive Cancer Center Berkley, California, United States
- Rocky Mountain Cancer Center Denver, Colorado, United States
- University of Florida Health Science Center at Jacksonville Jacksonville, Florida, United States
- New York Medical College Valhalla, New York, United States
Completed
Fasturtec TLS Treatment / Prophylysis
NCT00651911
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +3 more
- Locations
-
- Sanofi-Aventis Bridgewater, New Jersey, United States